Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 6

Abstract

Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the CBC changes in patients undergoing FAC and AC protocols. Methodology: A comparative retrospective study was performed to determine CBC changes in breast cancer patients following 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and cyclophosphamide (ACProtocol) among 150 breast cancer patients following 4 cycles of respective protocols. Marital status, surgical history, stages, diagnosis and receptor status were also determined. The parameters under observation were hemoglobin, platelets, MCV, MCHC, RBC’s, WBC’s, monocytes, lymphocytes, eosinophils and neutrophils. Data was analyzed using SPSS. Results: FAC and AC protocol influenced the values of CBC in breast cancer patients in different patterns. A mild decrease in the Hemoglobin level and a significant decrease in the value of RBC’s and significant increase in the level of MCV was observed in the study population after 4 cycles of both FAC and AC protocols of chemotherapy where most of the parameters such as platelets, MCV, Monocytes, Neutrophils, Eosinophils, Lymphocytes and WBCs remained in the normal range except hemoglobin, MCHC and RBCs by the end of 4th cycle of the therapy. Conclusion: No significant difference was observed with the CBC changes in both protocols. A frequent investigation of CBC parameters and careful selection of chemotherapy protocol should be done in patients who are prone to CBC disturbances.

Authors and Affiliations

Asif U, Yousaf M, Saleem Z*, Raza SA, Iftikhar N, Ibrahim K, Nasir Z, Saeed A and Bashir A

Keywords

Related Articles

A Review: Phytochemical and Pharmacology of Bryophyllum Pinnatum

Bryophyllum pinnatum is traditionally used plant belonging to family Crassulaceae. The plant is derived from the Greek words bryo, which means to sprout, and phyllon, which means leaf. Many plant parts include secondary...

Perceived Satisfaction of Public Health Facilities’ with the Quality of Logistics Service Provided by Pharmaceutical Fund and Supply Agency Bahirdar Hub, Northwest Ethiopia: Descriptive Study

Aim: This study aimed to investigate the satisfaction of public health facilities in the quality of logistics services received from the Pharmaceutical Fund and Supply Agency Bahirdar hub. Methodology: A descriptive re...

Virtual Screening and Validation of Potential Lead Compound from the Malaria Box against Plasmodium Falciparum S7 and S19 Proteins

Molecular docking is a computer based tool used in drug design, where predominant binding modes of a ligand with known three dimensional protein structures are predicted. This study addresses the possible ways of coming...

Mechanistic Insights of Rutin against Metabolic Disorders

Rutin, a quercetin glycoside comes under the class flavonol. The aglycone part of rutin is known as quercetin. It is found in numerous fruits and plants, especially apricots, buckwheat, cherries, grapefruit, grapes, ora...

Formulation Development and Evaluation of Mouth Dissolving Film of Taurine and Their Future Perspectives

This study focuses on the formulation development and evaluation of mouth dissolving films (MDFs) containing taurine, an amino acid with potential therapeutic benefits. Taurine-loaded MDFs were formulated using hydroxyp...

Download PDF file
  • EP ID EP745870
  • DOI 10.23880/oajpr-16000131
  • Views 45
  • Downloads 0

How To Cite

Asif U, Yousaf M, Saleem Z*, Raza SA, Iftikhar N, Ibrahim K, Nasir Z, Saeed A and Bashir A (2017). Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol). Open Access Journal of Pharmaceutical Research, 1(6), -. https://www.europub.co.uk/articles/-A-745870